Copyright
©The Author(s) 2022.
World J Gastroenterol. May 7, 2022; 28(17): 1751-1767
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1751
Published online May 7, 2022. doi: 10.3748/wjg.v28.i17.1751
Table 1 World Health Organization classification for gastroenteropancreatic neuroendocrine neoplasms1
Differentiation | Mitotic rate (%) | Ki-67 proliferation index (%) | |
G1 NET | Well-differentiated | < 2 | < 3 |
G2 NET | Well-differentiated | 2-20 | 3-20 |
G3 NET | Well-differentiated | > 20 | > 20 |
SCNEC | Poorly-differentiated | > 20 | > 20 |
LCNEC | Poorly-differentiated | > 20 | > 20 |
MiNEN | Well- or poorly-differentiated | Variable | Variable |
- Citation: Yin F, Wu ZH, Lai JP. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(17): 1751-1767
- URL: https://www.wjgnet.com/1007-9327/full/v28/i17/1751.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i17.1751